The medical marijuana industry is in its infancy in the United States. A large number of individual states have legalized medical marijuana to varying levels of control and regulation.  Medical marijuana is illegal on a US Federal level but all predictions are that this situation will change…exactly when is not clear….but it is difficult if not impossible to “put the genie back into the bottle.”

Pharmaceutical products, foods, beverages, medical devices, Nutritionals, etc are all regulated in the US to some level and degree by the FDA under the Food Drug & Cosmetic Act. 

GMP refers to the Good Manufacturing Practice Regulations established by the US Food and Drug Administration under the act which has the force of law.  Those GMPs require that manufacturers, processors, and packagers of drugs, medical devices, some food, and blood products take proactive steps to ensure that their products are safe, pure, and effective.   Since medical marijuana is not a legally recognized and regulated medicinal product in the US, we can only review GMPs as they relate to the wide range of international and US individual state cannabis regulations along with existing non-cannabis GMPs to determine how to best operate our cannabis operations.

This webinar will provide a basic foundation for Good Manufacturing Practices essentially for any medical marijuana production operation.

It is critical as cannabis production takes its place in the mainstream of US medicinal production, that all companies currently operating under individual state auspices understand and align their operations with existing GMPs to be in compliance when cannabis is federally recognized. This webinar will provide the foundation to the understanding of GMPs in pharmaceuticals in terms of cannabis growing and production.